肠道免疫-慢性炎症与胰岛素抵抗及中医药治疗研究进展
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Research progress on intestinal immunity-chronic inflammation, insulin resistance and traditional Chinese medicine treatment
  • 作者:韩煦 ; 姚政 ; 李俊燕 ; 陆灏
  • 英文作者:HAN Xu;YAO Zheng;LI Jun-yan;LU Hao;Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Diabetes Research Institute;
  • 关键词:肠道免疫 ; 慢性炎症 ; 胰岛素抵抗 ; 中医药
  • 英文关键词:Intestinal immunity;;Chronic inflammation;;Insulin resistance;;Traditional Chinese medicine
  • 中文刊名:BXYY
  • 英文刊名:China Journal of Traditional Chinese Medicine and Pharmacy
  • 机构:上海中医药大学附属曙光医院内分泌科糖尿病研究所;
  • 出版日期:2019-06-01
  • 出版单位:中华中医药杂志
  • 年:2019
  • 期:v.34
  • 基金:国家自然科学基金项目(No.81774235,No.81403359)~~
  • 语种:中文;
  • 页:BXYY201906076
  • 页数:4
  • CN:06
  • ISSN:11-5334/R
  • 分类号:302-305
摘要
慢性炎症是胰岛素抵抗(IR)发生的根本原因。越来越多的证据表明,肠道免疫-慢性炎症是IR发生的重要因素之一,但其机制尚不完全清楚。近年来研究发现,中医药通过调节肠道免疫改善IR具有良好的疗效,且安全可靠。文章通过对肠道免疫-慢性炎症影响IR的相关机制及中医药研究现状进行总结,并提出中医药改善IR的研究方向。
        Chronic inflammation is primary cause of insulin resistance(IR). Growing evidence has implicated the intestinal immune-chronic inflammation as an important contributor to IR while its mechanism is not clear. In recent years, studies have manifested that traditional Chinese medicine has a practicable and safe therapeutic effect in the treatment of reducing IR through the regulation of intestinal immunity system. This review made a conclusion about mechanism of intestinal immunitychronic inflammation affecting IR and current situation of traditional Chinese medicine, and proposed the research direction of traditional Chinese medicine to relieve IR.
引文
[1]Hotamisligil G S,Shargill N S,Spiegelman B M.Adipose expression of tumor necrosis factor-alpha:Direct role in obesity-linked insulin resistance.Science,1993,259(5091):87-91
    [2]Magalhaes I,Pingris K,Poitou C,et al.Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.J Clin Invest,2015,125(4):1752-1762
    [3]Winer D A,Winer S,Dranse H J,et al.Immunologic impact of the intestine in metabolic disease.Journal of Clinical Investigation,2017,127(1):33-42
    [4]Winer D A,Luck H,Tsai S,et al.The intestinal immune system in obesity and insulin resistance.Cell Metab,2016,23(3):413-426
    [5]Cani P D,Bibiloni R,Knauf C,et al.Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.Diabetes,2008,57(6):1470-1481
    [6]Luck H,Tsai S,Chung J,et al.Regulation of obesity-related insulin resistance with gut anti-inflammatory agents.Cell Metab,2015,21(4):527-542
    [7]Al-Sadi R M,Ma T Y.IL-1 causes an increase in intestinal epithelial tight junction permeability.The Journal of Immunology,2007,178(7):4641-4649
    [8]Wang X,Ota N,Manzanillo P,et al.Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes.Nature,2014,514(7521):237-241
    [9]Cario E,Rosenberg I M,Brandwein S L,et al.Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors.J Immunol,2000,164(2):966-972
    [10]Furi I,Sipos F,Germann T M,et al.Epithelial toll-like receptor 9signaling in colorectal inflammation and cancer:Clinico-pathogenic aspects.World J Gastroenterol,2013,19(26):4119-4126
    [11]Peterson L W,Artis D.Intestinal epithelial cells:Regulators of barrier function and immune homeostasis.Nat Rev Immunol,2014,14(3):141-153
    [12]Pendyala S,Neff L M,Suarez-Farinas M,et al.Diet-induced weight loss reduces colorectal inflammation:implications for colorectal carcinogenesis.Am J Clin Nutr,2011,93(2):234-242
    [13]Ding S,Chi M M,Scull B P,et al.High-fat diet:Bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse.Plos One,2010,5(8):e12191
    [14]Johnson A M,Costanzo A,Gareau M G,et al.High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability.PLo S One,2015,10(4):e122195
    [15]Helen,Tsai,Sue,et al.Regulation of obesity-related insulin resistance with gut anti-inflammatory agents.Agents,2015,21(4):527-542
    [16]Monteiro-Sepulveda M,Touch S,Mendes-SáC,et al.Jejunal T cell inflammation in human obesity correlates with decreased enterocyte insulin signaling.Cell Metabolism,2015,22(1):113-124
    [17]Neuman H,Debelius J W,Knight R,et al.Microbial endocrinology:The interplay between the microbiota and the endocrine system.FEMS Microbiology Reviews,2015,39(4):509-521
    [18]Hall J A,Bouladoux N,Sun C M,et al.Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses.Immunity,2008,29(4):637-649
    [19]Ries M,Schuster P,Thomann S,et al.Identification of novel oligonucleotides from mitochondrial DNA that spontaneously induce plasmacytoid dendritic cell activation.J Leukoc Biol,2013,94(1):123-135
    [20]Bouladoux N,Hall J A,Grainger J R,et al.Regulatory role of suppressive motifs from commensal DNA.Mucosal Immunol,2012,5(6):623-634
    [21]Elce A,Amato F,Zarrilli F,et al.Butyrate modulating effects on proinflammatory pathways in human intestinal epithelial cells.Benef Microbes,2017,8(5):841-847
    [22]Davis-Richardson A G,Triplett E W.A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes.Diabetologia,2015,58(7):1386-1393
    [23]Honda K,Littman D R.The microbiome in infectious disease and Inflammation.Annual Review of Immunology,2012,30(1):759-795
    [24]邵加庆.代谢性疾病防控的新大陆——肠道菌群.医学研究生报,2016,29(1):16-20
    [25]Zhao L,Cen F,Tian F,et al.Combination treatment with quercetin and resveratrol attenuates high fat diet-induced obesity and associated inflammation in rats via the AMPKalpha1/SIRT1signaling pathway.Exp Ther Med,2017,14(6):5942-5948
    [26]Bai J,Zhu Y,Dong Y.Response of gut microbiota and inflammatory status to bitter melon(Momordica charantia L.)in high fat diet induced obese rats. J Ethnopharmacol,2016,194:717-726
    [27]Vazquez-Prieto M A,Bettaieb A,Haj F G,et al.(-)-Epicatechin prevents TNFalpha-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1adipocytes.Arch Biochem Biophys,2012,527(2):113-118
    [28]Xu J H,Liu X Z,Pan W,et al.Berberine protects against dietinduced obesity through regulating metabolic endotoxemia and gut hormone levels.Mol Med Rep,2017,15(5):2765-2787
    [29]Ye L,Liang S,Guo C,et al.Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance.Life Sci,2016,166:82-91
    [30]Wei Y,Gao J,Qin L,et al.TanshinoneⅠalleviates insulin resistance in type 2 diabetes mellitus rats through IRS-1 pathway.Biomed Pharmacother,2017,93:352-358
    [31]Lou T,Zhang Z,Xi Z,et al.Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes.Inflammation,2011,34(6):659-667
    [32]王超,张会欣,邢邯英,等.氧化苦参碱抑制p38MAPK通路减轻高脂喂养胰岛素抵抗小鼠氧化应激.中国中药杂志,2016,41(15):2872-2876
    [33]Yang S J,Choi J M,Park S E,et al.Preventive effects of bitter melon(Momordica charantia)against insulin resistance and diabetes are associated with the inhibition of NF-kappa B and JNK pathways in high-fat-fed OLETF rats.J Nutr Biochem,2015,26(3):234-240
    [34]Yang X,Li L,Fang K,et al.Wu-Mei-Wan reduces insulin resistance via inhibition of NLRP3 inflammasome activation in HepG2 cells.Evid Based Complement Alternat Med,2017,2017:7283241
    [35]Jiang C,Yao N,Wang Q,et al.Cyclocarya paliurus extract modulates adipokine expression and improves insulin sensitivity by inhibition of inflammation in mice.J Ethnopharmacol,2014,153(2):344-351
    [36]侯丽琼,赵铁耘,张伊祎.黄连素对肥胖胰岛素抵抗大鼠骨骼肌胰岛素抵抗的干预研究.四川大学学报(医学版),2015,46(6):827-831
    [37]Chang W,Chen L,Hatch G M.Berberine treatment attenuates the palmitate-mediated inhibition of glucose uptake and consumption through increased 1,2,3-triacyl-sn-glycerol synthesis and accumulation in H9c2 cardiomyocytes.Biochim Biophys Acta,2016,1861(4):352-362
    [38]Zhao L,Zhang Q,Ma W,et al.A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota.Food Funct,2017,8(12):4644-4656
    [39]Wang J H,Kim B S,Han K,et al.Ephedra-Treated Donor-Derived Gut Microbiota Transplantation Ameliorates High Fat Diet-Induced Obesity in Rats.Int J Environ Res Public Health,2017,14(6):555
    [40]Wang W,Zhao J,Gui W,et al.Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with nonalcoholic fatty liver disease.Br J Pharmacol,2018,175(3):469-484
    [41]章常华,马广强,邓永兵,等.葛根芩连汤对KK-Ay糖尿病小鼠血浆中LPS、TNF-α、IL-6及肠道菌群的影响.中草药,2017,48(8):1611-1616

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700